AHA Coding Clinic® for HCPCS - 2015 Issue 4; For your information
Code changes for HCPCS C-codes and Q-codes
Effective January 1, 2016, several temporary drug HCPCS C-codes and Q-codes will be replaced with permanent HCPCS J-codes. For a listing of the HCPCS code changes see the table below. CY 2015 CPT/HCPCS codeCY 2016 CPT/HCPCS codeCY 2016 Long descriptorC9445 J0596 Injection, c1 esterase inhibitor (recombinant), Ruconest, 10 units C9448* J8655 Netupitant 300 mg and palonosetron 0.5 mg C9449 J9039 Injection, blinatumomab, 1 microgram C9450 J7313 Injection, fluocinolone acetonide intravitreal implant, 0.01 mg C9451 J2547 Injection, peramivir, 1 mg C9452 J0695 Injection, ceftolozane 50 mg and tazobactam 25 mg C9453 J9299 Injection, nivolumab, 1 mg C9454 J2502...
Subscribe or sign in to view the full article.
Article Overview
This article reviews HCPCS coding updates effective January 1, 2016, with emphasis on temporary drug code replacements and the transition to permanent J-codes. It is relevant to coders, billing staff, and reimbursement professionals who track HCPCS updates and need to understand which code identifiers are changing across the listed drug-related entries. The article centers on a tabular mapping of prior codes to newer codes and includes a note about a previously deleted code that was later replaced.
Why This Topic Matters
HCPCS code updates can affect charge capture, claims processing, and code maintenance workflows. Knowing which identifiers changed helps coding and billing teams keep reference files current and avoid using outdated codes.
Article Sections
-
Effective January 1, 2016 code changes
Overview of the effective date and the scope of HCPCS updates covered in the article. The section introduces the general transition from temporary to permanent drug-related identifiers.
-
Code change table
Tabular listing of prior HCPCS identifiers and their updated counterparts. The section organizes the affected drug-related entries referenced in the article.
-
Footnote on C9448
A short note describing the historical status of one identifier and its replacement sequence. The note provides context for the table entry without expanding into broader guidance.
What You Will Learn
- The general scope of HCPCS drug code updates covered in the article
- How the article presents prior and updated code identifiers in table form
- What contextual note is included about one previously deleted code
- Which code families are involved in the transition discussed by the article
Who Should Read This
- Medical coders
- Billing staff
- Charge capture teams
- Revenue cycle professionals
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com